- Home
- HCM vs DKL Comparison
HCM vs DKL Comparison
Compare HCM & DKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCM
- DKL
- Stock Information
- Founded
- HCM 2000
- DKL 2012
- Country
- HCM Hong Kong
- DKL United States
- Employees
- HCM N/A
- DKL N/A
- Industry
- HCM Biotechnology: Pharmaceutical Preparations
- DKL Natural Gas Distribution
- Sector
- HCM Health Care
- DKL Energy
- Exchange
- HCM Nasdaq
- DKL Nasdaq
- Market Cap
- HCM 2.5B
- DKL 2.3B
- IPO Year
- HCM N/A
- DKL N/A
- Fundamental
- Price
- HCM $15.60
- DKL $42.80
- Analyst Decision
- HCM Hold
- DKL Buy
- Analyst Count
- HCM 1
- DKL 4
- Target Price
- HCM $19.00
- DKL $44.25
- AVG Volume (30 Days)
- HCM 85.9K
- DKL 102.3K
- Earning Date
- HCM 07-30-2025
- DKL 08-05-2025
- Dividend Yield
- HCM N/A
- DKL 10.41%
- EPS Growth
- HCM N/A
- DKL 7.97
- EPS
- HCM 0.04
- DKL 2.98
- Revenue
- HCM $630,201,000.00
- DKL $938,491,000.00
- Revenue This Year
- HCM $14.86
- DKL $21.19
- Revenue Next Year
- HCM $19.54
- DKL N/A
- P/E Ratio
- HCM $70.47
- DKL $14.30
- Revenue Growth
- HCM N/A
- DKL N/A
- 52 Week Low
- HCM $11.51
- DKL $34.59
- 52 Week High
- HCM $21.50
- DKL $45.71
- Technical
- Relative Strength Index (RSI)
- HCM 53.32
- DKL 54.22
- Support Level
- HCM $14.86
- DKL $42.05
- Resistance Level
- HCM $16.00
- DKL $43.18
- Average True Range (ATR)
- HCM 0.33
- DKL 0.85
- MACD
- HCM -0.12
- DKL -0.14
- Stochastic Oscillator
- HCM 27.27
- DKL 37.38
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
About DKL Delek Logistics Partners L.P. Common Units representing Limited Partner Interests
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.